SCHEMBL4040645

SCHEMBL4040645

CCc1nn2ccccc2c1NC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.43
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KLF5 Q13887 1/20 0.42
MAPT P10636 4/20 0.41
ALDH1A1 P00352 3/20 0.41
EGFR P00533 1/20 0.41
ALOX15 P16050 1/20 0.40
MIF P14174 2/20 0.40
KCNH2 Q12809 1/20 0.40
GAA P10253 1/20 0.40
TP53 P04637 1/20 0.40
PDE5A O76074 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5847931 0.90 MAP4K4 (0.47) HDAC1NPC1RAB9AMEN1KMT2A
SCHEMBL17047960 0.84 ALDH1A1 (0.43) HDAC1NPC1RAB9AMEN1KMT2A
SCHEMBL5847495 0.84 ALDH1A1 (0.42) HDAC1NPC1RAB9AMEN1KMT2A
SCHEMBL5848211 0.84 TSHR (0.42) HDAC1NPC1RAB9AMEN1KMT2A
SCHEMBL4035121 0.83 BRD4 (0.39) HDAC1NPC1RAB9AMEN1KMT2A
SCHEMBL1942386 0.81 HTR6 (0.40) NPC1RAB9AMEN1KMT2ANPSR1
SCHEMBL4035512 0.80 MMP12 (0.47) HDAC1SMN1; SMN2ALDH1A1KCNH2LMNA
SCHEMBL22194219 0.79 LMNA (0.36) HDAC1NPC1RAB9AKMT2ANPSR1
SCHEMBL2035471 0.79 EGFR (0.48) HDAC1NPC1RAB9AMEN1KMT2A
SCHEMBL6489306 0.76 DRD2 (0.39) HDAC1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174647-A1 KINASE MODULATORS AND METHODS OF USE THEREOF NEURON23, INC. 2024-05-30 US disclosed
EP-1555265-B1 7-PHENYL PYRAZOLOPYRIDINE COMPOUNDS EISAI R&D MAN CO LTD (JP) 2009-03-25 EP disclosed
US-20080076943-A1 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS HIBI SHIGEKI 2008-03-27 US disclosed
US-7323569-B2 7-phenylpyrazolopyridine compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-01-29 US disclosed
US-7176216-B2 7-phenylpyrazolopyridine compounds EISAI CO., LTD. (JP) 2007-02-13 US disclosed
US-20060235011-A1 7-Phenyl pyrazolopyridine compounds EISAI CO.LTD. (JP) 2006-10-19 US disclosed
EP-1555265-A1 7-PHENYL PYRAZOLOPYRIDINE COMPOUNDS Eisai Co., Ltd. (JP) 2005-07-20 EP disclosed
US-20040224974-A1 7-phenylpyrazolopyridine compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040224974-A1 7-phenylpyrazolopyridine compounds CRHR1, MC2R, CRH HDAC1 1024/4885NPC1 2600/4885RAB9A 1446/4885
US-20080076943-A1 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS MC2R, CRHR1, CRHR2 HDAC1 1157/4885NPC1 2954/4885RAB9A 1415/4885
US-20060235011-A1 7-Phenyl pyrazolopyridine compounds MC2R, CRHR1, CRHR2 HDAC1 1080/4885NPC1 3036/4885RAB9A 1273/4885
US-20240174647-A1 KINASE MODULATORS AND METHODS OF USE THEREOF LRRK2, MAP3K20, MAP3K5 HDAC1 1339/4885NPC1 2422/4885RAB9A 917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.